Journal Article

Clinical Effect Analysis of Different Doses of Creatine Phosphate Sodium Combined with Immunoglobulin in the Treatment of Pediatric Viral Myocarditis

Xing, Shuhua, Wang, Meng, Deng, Jiegang, Li, Lu

2024

Overview

The purpose of this paper was to unravel the clinical effect analysis of different doses of creatine phosphate sodium (CPS) combined with immunoglobulin in the treatment of pediatric viral myocarditis (VMC). One hundred and twenty children with VMC were recruited and randomized into three groups (40 patients each). Group I received 1.0 g of CPS dissolved in 100 mL of 5% glucose injection intravenously 1 time/day; group II received 1.25 g of CPS dissolved in 125 mL of 5% glucose injection intravenously 1 time/day; group III received 1.5 g of CPS dissolved in 150 mL of 5% glucose injection intravenously 1 time/day; then all three groups were treated with combined use of immunoglobulin (300–400 mg/day) intravenously once a day; and all three groups were treated for 14 days. The clinical efficacy, cardiac function, serum inflammatory factor levels, immune function, and the occurrence of drug toxicity and adverse effects of the children in the three groups were compared after 14 days of treatment. All three groups achieved better therapeutic effects after treatment, in which the effective rate of the Group II and Group III was notably higher versus the Group I. Lower levels of cTnI, CK-MB, LDH, AST, IL-18, IL-6, IFN-γ, and LVEDD and higher CD3 + , CD4 + , and CD4 + /CD8 + , FS, and LVEF values were noted in the Group II and Group III versus the Group I, and the results were more pronounced in the high-dose group. The liver and kidney functions of the children in the three groups before and after treatment did not show any significant changes and the incidence of adverse reactions during the treatment period was low in all three groups. Children with VMC can be treated with high-dose CPS in combination with immunoglobulin, which can improve their cardiac function and immune function and reduce the inflammatory response with good overall therapeutic efficacy and fewer adverse effects.

• Publisher: Springer US,Springer,Springer Nature B.V
• Subject: Cardiac arrhythmia / Cardiac function / Cardiac Surgery / Cardiology / Cardiovascular disease / Child / Child, Preschool / Cytokines / Dosage and administration / Dose-Response Relationship, Drug / Drug dosages / Drug therapy / Drug Therapy, Combination / Electrocardiography / Enzymes / Female / Glucose / Heart rate / Hospitals / Humans / Immunoglobulins / Immunoglobulins - administration & dosage / Immunoglobulins - therapeutic use / Kinases / Leukocytes / Male / Medicine / Medicine & Public Health / Myocarditis / Myocarditis - drug therapy / Normal distribution / Patient outcomes / Pediatric research / Pediatrics / Phosphocreatine / Side effects / Treatment Outcome / Vascular Surgery / Virus diseases / Virus Diseases - drug therapy